We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Researchers from Protein Production UK, a collaborative project led by The Rosalind Franklin Institute, have isolated nanobodies - a type of antibody used in research, which bind to the 'spike' protein of the SARS-CoV-2 virus.